Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bockel

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 11, 2018
Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applicationsS Bockel, B Durand, E Deutsch
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 12, 2016
[Radiotherapy and targeted therapy/immunotherapy]D Antoni, S Bockel, E Deutsch, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 20, 2017
[Immunotherapy and radiotherapy]S Bockel, D Antoni, É Deutsch, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2021
[Extreme hypofractionation: New indications for breast cancer radiotherapy]S Bockel, G Louvel, T Brion, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 26, 2022
Interactions of radiation therapy with common and innovative systemic treatments: Antidiabetic treatments, antihypertensives, lipid-lowering medications, immunosuppressive medications and other radiosensitizing methodsY Zhou, A Larnaudie, Y Ghannam, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 20, 2018
Pharmacological modulation of radiation-induced oral mucosal complicationsS Bockel, A Vallard, A Lévy, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 casesS Benhmida, R Sun, E Gherga, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 1, 2020
Evaluation of adjuvant vaginal vault brachytherapy in early stage cervical cancer patientsE Bronsart, C Petit, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2021
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignanciesF Pommeret, J Colomba, C Bigenwald, et al.
Gynecologic Oncology|March 17, 2020
Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapyF Mignot, S Gouy, A Schernberg, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 11, 2018
Combining radiation therapy and cancer immune therapies: From preclinical findings to clinical applicationsS Bockel, B Durand, E Deutsch
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 12, 2016
[Radiotherapy and targeted therapy/immunotherapy]D Antoni, S Bockel, E Deutsch, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 20, 2017
[Immunotherapy and radiotherapy]S Bockel, D Antoni, É Deutsch, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 28, 2021
[Extreme hypofractionation: New indications for breast cancer radiotherapy]S Bockel, G Louvel, T Brion, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|August 26, 2022
Interactions of radiation therapy with common and innovative systemic treatments: Antidiabetic treatments, antihypertensives, lipid-lowering medications, immunosuppressive medications and other radiosensitizing methodsY Zhou, A Larnaudie, Y Ghannam, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 20, 2018
Pharmacological modulation of radiation-induced oral mucosal complicationsS Bockel, A Vallard, A Lévy, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 4, 2020
Split-course hypofractionated radiotherapy for aged and frail patients with head and neck cancers. A retrospective study of 75 casesS Benhmida, R Sun, E Gherga, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 1, 2020
Evaluation of adjuvant vaginal vault brachytherapy in early stage cervical cancer patientsE Bronsart, C Petit, S Gouy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2021
Bamlanivimab + etesevimab therapy induces SARS-CoV-2 immune escape mutations and secondary clinical deterioration in COVID-19 patients with B-cell malignanciesF Pommeret, J Colomba, C Bigenwald, et al.
Gynecologic Oncology|March 17, 2020
Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapyF Mignot, S Gouy, A Schernberg, et al.
Pageof 2